A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23.
Saito Y, Yin D, Kubota N, Wang X, Filliol A, Remotti H, Nair A, Fazlollahi L, Hoshida Y, Tabas I, Wangensteen KJ, Schwabe RF.
Saito Y, et al. Among authors: remotti h.
Gastroenterology. 2023 Jun;164(7):1279-1292. doi: 10.1053/j.gastro.2023.02.043. Epub 2023 Mar 7.
Gastroenterology. 2023.
PMID: 36894036
Free PMC article.